Back

Combined hs-cTnT and NT-proBNP plasma levels identify patients with high risk stable coronary artery disease and early LV dysfunction.

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Biomarkers Natriuretic peptides HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Chiara Caselli

CNR – National Research Council, Pisa (Italy)

24 More presentations in this session

Presentation thumbnail
C-type natriuretic peptide in human blood of adolescent with different degree of endothelial dysfunction: a different trend for plasma levels and mRNA expression.
Doctor M. Cabiati (Pisa, IT)
Presentation thumbnail
Unexpected age-sex distribution of NP measurements and concentrations : results of Big Data analysis
Professor C. Meune (Bobigny, FR)
Abstract
Presentation thumbnail
Potential prognostic and clinical role of early measurement of N-terminal pro brain natriuretic peptide (NT-proBNP) in patients of acute coronary syndrome
Doctor M. Gegenava (Tbilisi, GE)
Presentation thumbnail
Patterns and prognostic Role of N-terminal pro-B-type natriuretic peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction
Professor G. Savarese (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Brain natriuretic peptide: a potential modifier of the pharmacodynamic response to antiplatelet agents in acute heart failure
Professor L. Malinova (Saratov, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Biomarkers

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources